Eledon Pharmaceuticals Inc (ELDN)
4.13
-0.14
(-3.28%)
USD |
NASDAQ |
Nov 14, 16:00
4.03
-0.10
(-2.42%)
After-Hours: 20:00
Eledon Pharmaceuticals Shareholders Equity (Quarterly): -8.501M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -8.501M |
| March 31, 2024 | 74.82M |
| December 31, 2023 | 7.208M |
| September 30, 2023 | 91.34M |
| June 30, 2023 | 99.95M |
| March 31, 2023 | 74.79M |
| December 31, 2022 | 84.18M |
| September 30, 2022 | 141.09M |
| June 30, 2022 | 149.38M |
| March 31, 2022 | 156.32M |
| December 31, 2021 | 164.00M |
| September 30, 2021 | 170.75M |
| June 30, 2021 | 178.52M |
| March 31, 2021 | 183.87M |
| December 31, 2020 | 190.60M |
| September 30, 2020 | 21.51M |
| June 30, 2020 | 9.356M |
| March 31, 2020 | 11.74M |
| December 31, 2019 | 9.465M |
| September 30, 2019 | 13.37M |
| June 30, 2019 | 16.03M |
| Date | Value |
|---|---|
| March 31, 2019 | 9.929M |
| December 31, 2018 | 14.49M |
| September 30, 2018 | 18.32M |
| June 30, 2018 | 21.51M |
| March 31, 2018 | 24.30M |
| December 31, 2017 | 19.45M |
| September 30, 2017 | 20.62M |
| June 30, 2017 | 23.44M |
| March 31, 2017 | 23.36M |
| December 31, 2016 | -2.702M |
| September 30, 2016 | 30.26M |
| June 30, 2016 | 38.88M |
| March 31, 2016 | 51.41M |
| December 31, 2015 | 61.72M |
| September 30, 2015 | 71.90M |
| June 30, 2015 | 82.75M |
| March 31, 2015 | 90.90M |
| December 31, 2014 | 103.50M |
| September 30, 2014 | 101.61M |
| June 30, 2014 | 19.73M |
| December 31, 2013 | -55.27M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-8.501M
Minimum
Jun 2024
190.60M
Maximum
Dec 2020
95.28M
Average
91.34M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 120.48M |
| Total Liabilities (Quarterly) | 128.98M |